CJC-1295 + Ipamorelin
A single combined vial pairing CJC-1295 (no DAC / Mod GRF 1-29) with Ipamorelin — a GHRH analog and a selective ghrelin-receptor agonist studied together for their complementary action on the somatotropic axis. Supplied as 5 mg CJC-1295 + 5 mg Ipamorelin per 10 mg vial.
The classic GHRH + ghrelin-mimetic pairing in a single vial.
What it is
This is a single combined vial pairing CJC-1295 no DAC (Modified GRF 1-29), a short-acting GHRH analog, with Ipamorelin, a selective ghrelin-receptor (GHS-R) agonist. The two are studied together because they act on complementary pathways of the somatotropic axis.
Each 10 mg vial contains 5 mg CJC-1295 no DAC and 5 mg Ipamorelin, lyophilized and sealed under nitrogen. Supplied strictly for in-vitro and pre-clinical laboratory research.
Reconstitution & storage
- Reconstitute with bacteriostatic water — add slowly down the vial wall and swirl gently; do not shake.
- Store lyophilized vials at -20C; once reconstituted keep at 2-8C and use within 16 weeks.
- Protect from light and avoid repeated freeze-thaw cycles.
Cited research applications
Questions
Related compounds
For Research Use Only. Not for human or animal consumption. This product has not been evaluated by the Food and Drug Administration. Not intended to diagnose, treat, cure, or prevent any disease. CJC-1295 + Ipamorelin is sold strictly as a research chemical for in-vitro and pre-clinical laboratory investigation only.